Prevalence of Pertussis Antibodies in Maternal Delivery, Cord, and Infant Serum
The Journal of Infectious Diseases2004Vol. 190(2), pp. 335–340
Citations Over TimeTop 10% of 2004 papers
Abstract
Despite efficient placental transfer, low maternal pertussis antibody levels and their rapid decay in infant sera leave infants with little humoral protection against pertussis. These data support the rationale for maternal or neonatal immunization, with acellular pertussis vaccines, to prevent life-threatening pertussis in early infancy.
Related Papers
- → Characterization of Two Adhesins of Bordetella pertussis for Human Ciliated Respiratory-Epithelial Cells(1985)225 cited
- → Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France(1996)101 cited
- → Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model(2008)69 cited
- Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia.(1985)
- → New acellular anti-pertussis vaccine; pertussis toxin protein engineering; filamentous hemagglutinin and 69 kDa protein production by Bordetella pertussis deletion mutant(1992)